Literature DB >> 2093630

Who is responsible for what?

J M Rouzioux1.   

Abstract

During the phase I trials, from the juridical point of view, the responsibilities are shared between the pharmaceutical company and the physician who manages the trial. The pharmaceutical company is responsible for the product, the choice of methodology and respect for the regulations. On the financial side, the company is liable for paying any damages. While the trial is being conducted, the physician is responsible both for the choice of the healthy volunteers and for their care.

Mesh:

Year:  1990        PMID: 2093630     DOI: 10.1111/j.1472-8206.1990.tb00077.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  1 in total

1.  Influence of the Purkinje-muscle junction on transmural repolarization heterogeneity.

Authors:  Richard D Walton; Marine E Martinez; Martin J Bishop; Mélèze Hocini; Michel Haïssaguerre; Gernot Plank; Olivier Bernus; Edward J Vigmond
Journal:  Cardiovasc Res       Date:  2014-07-03       Impact factor: 10.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.